Cronos Group Inc vs iShares Self-Driving EV and Tech — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.18B), while iShares Self-Driving EV and Tech trades at $33.26 (market cap $264.50M). The key difference: Cronos Group Inc is far larger — about 4.5× iShares Self-Driving EV and Tech's market cap, and Cronos Group Inc is trading nearer its 52-week high, iShares Self-Driving EV and Tech nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and iShares Self-Driving EV and Tech for 73 Days on average.
| CRON | IDRV | |
|---|---|---|
Market Cap | $1.18B | $264.50M |
Volume | 968,037 | 48,021 |
Sector | Health | Sector/Thematic |
52-Week High | $3.55 | $45.48 |
52-Week Low | $2.30 | $32.68 |
Typical Hold Time | 22 Days | 73 Days |
Enterprise Value | $387.62M | — |
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.22, down 0.62% on the day, with a bearish technical signal and neutral oscillators. Revenue grew to $146.59M in 2025, but net income was -$9.45M. Recent Q2 2026 earnings beat expectations with EPS of $0.09. The company held its first Investor Day in September 2026, highlighting international expansion and cash flow focus.
Outlook is mixed: strong revenue growth and a solid balance sheet with no debt support upside, but profitability remains inconsistent. Risks include cash flow volatility and competitive pressures. Analyst consensus is cautious with 60% hold ratings, reflecting uncertainty amid expansion efforts.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →IDRV invests in global companies at the forefront of self-driving and electric vehicle innovation. It provides exposure to the full EV value chain, including battery technology and autonomous systems, with top holdings like Albemarle, Rivian, and Tesla.
Read more on IDRV →